Characteristic | AA Patients ( n = 89) | MDS Patients ( n = 71) | Validation Cohort ( n = 86) | P-value | |
---|---|---|---|---|---|
AA Patients ( n = 57) | MDS Patients ( n = 29) | ||||
Gender | |||||
Male[(n, %)] | 39 (43.820) | 44 (61.972) | 24 (42.105) | 15 (51.724) | 0.022 |
Female[(n, %)] | 50 (56.180) | 27 (38.028) | 33 (57.895) | 14 (48.276) | |
Age [year (median IQR)] | 61.000 (56.000–68.500) | 69.000 (61.000–73.000) | 60.000 (55.000–69.000) | 65.000 (59.000–69.000) | < 0.001 |
Basic disease | |||||
Yesa[(n, %)] | 50 (56.180) | 43 (60.563) | 18 (31.579) | 17 (58.621) | 0.577 |
No[(n, %)] | 39 (43.820) | 28 (39.437) | 39 (68.421) | 12 (41.379) | |
Comorbidities [(n, %)] | |||||
Tumorb | 5 (5.618) | 10 (14.085) | 4 (7.018) | 6 (20.690) | 0.068 |
Hypertension | 26 (29.213) | 20 (28.169) | 8 (14.035) | 7 (24.138) | 0.885 |
Diabetes | 15 (16.854) | 11 (15.493) | 5 (8.772) | 4 (13.793) | 0.817 |
Infectious fever | 11 (12.360) | 7 (9.859) | 3 (5.263) | 1 (3.448) | 0.619 |
Hypoproteinemia | 5 (5.618) | 5 (7.042) | 1 (1.754) | 1 (3.448) | 0.712 |
Coronary heart disease | 2 (2.247) | 3 (4.225) | 1 (1.754) | 0 (0.000) | 0.475 |